Bioadaptives, Inc.

No trades
See on Supercharts
Market capitalization
‪465.88 K‬USD
−0.0015USD
‪−895.57 K‬USD
‪17.18 K‬USD
‪752.52 M‬
Beta (1Y)
8.04

About Bioadaptives, Inc.

Sector
CEO
Edward E. Jacobs
Headquarters
Las Vegas
Employees (FY)
7
Founded
2013
ISIN
US09072U1079
FIGI
BBG005NLFMC8
BioAdaptives, Inc. engages in marketing, investigating, and distributing natural plant and algal-based products that improve health and wellness for humans and animals. Its products include PrimiCell, PluriPain, and PrimiLung for humans, and Canine Regen and Equine Regen for dogs and horses. The company was founded on April 19, 2013 and is headquartered in Las Vegas, NV.
Performance
Revenue to profit conversion
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Stocks, Forex, Futures, Bonds
4.5Great

See all brokers